|
C12ORF23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33226762955019E-15 |
| Normal-vs-Stage2 |
7.50570000040973E-07 |
| Normal-vs-Stage3 |
7.105427357601E-14 |
| Normal-vs-Stage4 |
1.74504855010582E-12 |
| Stage1-vs-Stage2 |
4.103200E-01 |
| Stage1-vs-Stage3 |
2.963600E-01 |
| Stage1-vs-Stage4 |
5.162200E-03 |
| Stage2-vs-Stage3 |
1.531040E-01 |
| Stage2-vs-Stage4 |
1.311520E-02 |
| Stage3-vs-Stage4 |
1.350150E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.92295134949472E-12 |
| Normal-vs-AfricanAmerican |
9.831500E-04 |
| Normal-vs-Asian |
2.08739692197923E-11 |
| Caucasian-vs-AfricanAmerican |
1.946420E-01 |
| Caucasian-vs-Asian |
6.167200E-01 |
| AfricanAmerican-vs-Asian |
1.499030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2445600106048E-13 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.935000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.71149818948425E-11 |
| Normal-vs-Age(41-60Yrs) |
1.57651669496772E-13 |
| Normal-vs-Age(61-80Yrs) |
3.97226695980635E-12 |
| Normal-vs-Age(81-100Yrs) |
5.960100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.452800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.075800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.924800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.424800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.930400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.290400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.200000E-03 |
| Classical-VS-Follicular |
4.388800E-01 |
| Classical-VS-Other |
5.146800E-01 |
| Classical-VS-Normal |
2.012500166515E-10 |
| Tall-VS-Follicular |
4.860500E-03 |
| Tall-VS-Other |
5.441800E-01 |
| Tall-VS-Normal |
5.80091530366644E-13 |
| Follicular-VS-Other |
4.606400E-01 |
| Follicular-VS-Normal |
5.68369999953688E-08 |
| Other-VS-Normal |
1.256550E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.43058914609173E-14 |
| Normal-vs-N1 |
1.65734093116043E-12 |
| N0-vs-N1 |
5.120700E-03 |
|
|
